-
公开(公告)号：US09808439B2
公开(公告)日：2017-11-07
申请号：US14848360
申请日：2015-09-09
Applicant: Macau University of Science and Technology
Inventor： Wen-zhe Ma , Sen-ling Feng , Xiao-jun Yao , Zhong-wen Yuan , Liang Liu , Ying Xie
IPC: A61K31/352 , A61K31/337 , A61K45/06 , A61K31/704
CPC classification number: A61K31/352 , A61K31/337 , A61K31/704 , A61K45/06 , A61K2300/00
Abstract: The present invention discloses a pharmaceutical composition of treating multidrug resistance cancer, comprising a citrus methoxyflavone and a chemotherapeutic drug, in which the citrus methoxyflavone is tangeretin. A method of treating multidrug resistance cancer comprising administrating citrus methoxyflavone and a chemotherapeutic drug is also disclosed.
-
112.发明申请公开(公告)号：US20170262007A1
公开(公告)日：2017-09-14
申请号：US15076643
申请日：2016-03-21
Applicant: Macau University of Science and Technology
Inventor： Li Zhiwu , Mohamed Ghaieth Abidi , Moncef Ben Smida , Mohamed Khalgui , Naiqi Wu
CPC classification number: G05F1/66 , G05B11/01 , G05B15/02 , G05B2219/39407 , H02J3/381 , H02J3/382 , H02J3/383 , H02J3/386 , H02J2003/001 , H02J2003/003 , H02J2003/007 , Y02E60/76 , Y02P80/114 , Y04S40/22
Abstract: The present invention deals with microgrids, which represent a new approach to integrate distributed energy resources economically reliably and efficiently. A microgrid can operate in a connected mode if it makes an energetic exchange with a main grid or in an island mode otherwise. In its island operation mode, a microgrid ensures its energy self-sufficiency. However, the availability of resources in this mode is greatly influenced by meteorological factors and the microgrid must satisfy the high requirements on intelligent power management in order to achieve high availability of energy. The present invention provides a multi-agent control system based on the production forecasting and loads shedding for high availability of the microgrid power supply.
-
公开(公告)号：US20170244329A1
公开(公告)日：2017-08-24
申请号：US15048157
申请日：2016-02-19
Applicant: Macau University of Science and Technology
Inventor： Xiaodong Li
IPC: H02M3/335
CPC classification number: H02M3/3376 , H02M3/33592 , H02M2001/0058 , Y02B70/1433 , Y02B70/1475 , Y02B70/1491
Abstract: A converter circuit regulating power transfer from a power source to a load includes a first switching circuit arranged to be connected across an output of the power source, and including a plurality of switches. A second switching circuit including a plurality of switches is arranged to be connected across an input of the load. An inductive component electrically connects the first switching circuit with the second switching circuit. A controller is operably connected with the plurality of switches in both the first and second switching circuits, and receives a control signal for controlling switching of the plurality of switches in both the first and second switching circuit; generates gating signals to be provided to the plurality of switches in both the first and second switching circuit based on the control signal; and provide the gating signals to the plurality of switches in both the first and second switching circuit.
-
114.发明授权公开(公告)号：US09675608B2
公开(公告)日：2017-06-13
申请号：US14925962
申请日：2015-10-28
Applicant: Macau University of Science and Technology
Inventor： Kam Wai Wong , Yuen Kwan Law , Liang Liu
IPC: A61K31/44 , A61K31/4745
CPC classification number: A61K31/4745
Abstract: The present invention discloses a method of treating cancer and/or multidrug-resistant cancer, comprising administering an effective amount of hernandezine or thalidezine. A pharmaceutical composition comprising hernandezine or thalidezine admixed with a pharmaceutical carrier for treating cancers and/or multidrug-resistant cancer is also disclosed.
-
公开(公告)号：US20170131300A1
公开(公告)日：2017-05-11
申请号：US15131243
申请日：2016-04-18
Applicant: Macau University of Science and Technology
Inventor： Jing-Rong Wang , Jia-Ning Mi , Zhi-Hong Jiang
CPC classification number: A61K36/068 , A61K31/133 , A61K31/164 , A61K31/688 , A61K2236/333 , A61K2236/39 , A61K2236/50 , A61K2236/53 , B01D15/426 , C12Q1/04 , G01N30/72 , G01N33/92 , G01N2030/027 , G01N2333/37 , G01N2405/08
Abstract: The present invention relates to a method of identifying and preferably quantifying at least one sphingolipid, in particular the sphingolipid portion in wild-type Cordyceps or Cordyceps derivates. A further aspect relates to a method of identifying wild-type Cordyceps in a Cordyceps sample as well as for identifying Cordyceps derivates in a Cordyceps sample. The methods of the present invention, thus, allow for determining the quality and safety of Cordyceps products and for advantageously differentiating between wild-type Cordyceps and Cordyceps derivates via the ratio and/or presence of certain sphingolipids especially suitable as markers.
-
Patent Agency Ranking
公开(公告)号：US20170128507A1
公开(公告)日：2017-05-11
申请号：US15131218
申请日：2016-04-18
Applicant: Macau University of Science and Technology
Inventor： Zhi-Hong Jiang , Jing-Rong Wang , Jia-Ning Mi , Junping Kou , Yuwei Han , Yingqiong Xu
IPC: A61K36/068 , A61K31/164 , A61K31/688 , A61K31/133
CPC classification number: A61K36/068 , A61K31/133 , A61K31/164 , A61K31/688 , A61K2236/333 , A61K2236/39 , A61K2236/50 , A61K2236/53 , B01D15/426 , C12Q1/04 , G01N30/34 , G01N30/72 , G01N30/7233 , G01N33/92 , G01N2030/009 , G01N2030/027 , G01N2333/37 , G01N2405/08
Abstract: A method of isolating at least one sphingolipid portion selected from a sphingoid base portion, a ceramide portion, a glycosphingolipid portion or a phosphosphingolipid portion from Cordyceps, in particular from wild-type Cordyceps, allows for obtaining sphingolipid portions having an increased amount of one of sphingoid bases, ceramides, glycosphingolipids or phosphosphingolipids. The sphingolipid portions isolated contained significant amounts of sphingolipids not reported so far, and possess exceptional immunosuppressive activities. A method of treating a subject suffering from an inflammatory disease like an autoimmune disease or an allergic disease includes administering sphingolipids isolated from Cordyceps, in particular from wild-type Cordyceps. A method of treating a subject suffering from an inflammatory disease includes administering certain sphingolipids to the subject. Still further in accordance with the present invention is a composition, in particular a pharmaceutical composition comprising at least one sphingolipid portion.
-
公开(公告)号：US20170111816A1
公开(公告)日：2017-04-20
申请号：US14945306
申请日：2015-11-18
Applicant: Macau University of Science and Technology
Inventor： Li Feng
CPC classification number: H04W28/021 , H04L1/1854 , H04L47/70 , H04W74/08 , H04W74/0816
Abstract: In widely deployed wireless “hot-spot” networks, nodes frequently join or leave, inelastic/elastic and saturated/non-satuarted flows coexist. In such dynamic and diverse environments, it is challenging to maximize the channel utilization while providing satisfactory user experiences. In this invention, one proposes a novel contention-on-demand (CoD) MAC scheme to address this problem. The CoD scheme consists of a fixed-CW algorithm, a dynamic-CW algorithm, and an admission control unit. The fixed-CW algorithm allows elastic flows to access limited system bandwidth; the dynamic-CW algorithm enables inelastic flows to contend for channel on demand and quickly adapt to network change; and the admission control unit rejects overloaded traffic for providing good user experiences. One then performs an asymptotic analysis to develop a simple but efficient admission control rule. Finally, extensive simulations verify that the scheme is very effective and the theoretical result is very accurate.
-
118.发明申请公开(公告)号：US20170083009A1
公开(公告)日：2017-03-23
申请号：US14919720
申请日：2015-10-21
Applicant: Macau University of Science and Technology
Inventor： Naiqi Wu , Fajun Yang , Yan Qiao , Mengchu Zhou
IPC: G05B19/418
CPC classification number: G05B19/4187 , G05B2219/31429 , G05B2219/45032 , Y02P90/205 , Y10S901/02 , Y10S901/41
Abstract: Since single and dual-arm tools behave differently, it is difficult to coordinate their activities in a hybrid multi-cluster tool that is composed of both single- and dual-arm tools. Aiming at finding an optimal one-wafer cyclic schedule for a treelike hybrid multi-cluster tool whose bottleneck tool is process-bound, the present work extends a resource-oriented Petri net to model such system. By the developed Petri net model, to find a one-wafer cyclic schedule is to determine robot waiting times. By doing so, it is shown that, for any treelike hybrid multi-cluster tool whose bottleneck tool is process-bound, there is always a one-wafer cyclic schedule. Then, computationally efficient algorithms are developed to obtain the minimal cycle time and the optimal one-wafer cyclic schedule. Examples are given to illustrate the developed method.
-
119.发明授权公开(公告)号：US09561222B2
公开(公告)日：2017-02-07
申请号：US14985419
申请日：2015-12-31
Applicant: Macau University of Science and Technology
Inventor： Kam Wai Wong , Yuen Kwan Law , Liang Liu , Jingrong Wang
IPC: A61K31/4725 , A61K31/4745 , A61K31/4748
CPC classification number: A61K31/4745 , A61K31/4725 , A61K31/4748
Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
-
120.发明授权公开(公告)号：US09561219B2
公开(公告)日：2017-02-07
申请号：US14985408
申请日：2015-12-31
Applicant: Macau University of Science and Technology
Inventor： Kam Wai Wong , Yuen Kwan Law , Liang Liu , Jingrong Wang
IPC: A61K31/4725 , A61K31/4745 , A61K31/4748
CPC classification number: A61K31/4745 , A61K31/4725 , A61K31/4748
Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
-
-
-
-
-
-
-
-
-
Search Results
245
records
(took 0.026 seconds)
